Conference
Major arterial resection for stage 3 adenocarcinoma of the pancreas.
Abstract
362
Background: Stage 3 pancreas ductal adenocarcinoma (PDAC) is defined by arterial involvement, and its resection remains controversial. The objective of this study was to evaluate clinical and oncologic outcomes for patients with stage 3 PDAC who entered a treatment program of neoadjuvant therapy (NAT) and pancreatic resection, with comparison between those who underwent arterial (AR) vs. standard resection (SR). Methods: …
Authors
Loveday B; Tomiyama K; Zilbert N; Tremblay St-Germain A; Serrano Aybar PE; Fox A; Segedi M; Scholtz P; O'Malley M; Borgida A
Volume
36
Pagination
pp. 362-362
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 1, 2018
DOI
10.1200/jco.2018.36.4_suppl.362
Conference proceedings
Journal of Clinical Oncology
Issue
4_suppl
ISSN
0732-183X